India - English - Central Drugs Standard Control Organization

warner - pentaerythrityl tetranitrate - tab - 80mg - 10

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - methylprednisolone aceponate - ointment - 0.1%w/w percent weight/weight - methylprednisolone aceponate

Ireland - English - HPRA (Health Products Regulatory Authority)

leo pharma a/s - methylprednisolone aceponate - ointment - 0.1 percent weight/weight - methylprednisolone aceponate

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - buprenorphine, quantity: 40 mg - patch, dermal - excipient ingredients: oleyl oleate; polyethylene; povidone; levulinic acid; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; butyl acrylate; acrylic acid; 2,2'-azobisisobutyronitrile; aluminium acetylacetonate; heptane; acrylates copolymer; ethylene distearamide; adipic acid/1,4-butanediol/mdi copolymer; pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate - buprenorphine sandoz patches are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. buprenorphine sandoz patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. buprenorphine sandoz patches are not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - buprenorphine, quantity: 30 mg - patch, dermal - excipient ingredients: oleyl oleate; polyethylene; povidone; levulinic acid; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; butyl acrylate; acrylic acid; 2,2'-azobisisobutyronitrile; aluminium acetylacetonate; heptane; acrylates copolymer; ethylene distearamide; adipic acid/1,4-butanediol/mdi copolymer; pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate - buprenorphine sandoz patches are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. buprenorphine sandoz patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. buprenorphine sandoz patches are not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - buprenorphine, quantity: 25 mg - patch, dermal - excipient ingredients: oleyl oleate; polyethylene; povidone; levulinic acid; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; butyl acrylate; acrylic acid; 2,2'-azobisisobutyronitrile; aluminium acetylacetonate; heptane; acrylates copolymer; ethylene distearamide; adipic acid/1,4-butanediol/mdi copolymer; pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate - buprenorphine sandoz patches are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. buprenorphine sandoz patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. buprenorphine sandoz patches are not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

bondi sands pty ltd - homosalate, quantity: 100 mg/g; octocrylene, quantity: 60 mg/g; butyl methoxydibenzoylmethane, quantity: 40 mg/g - stick - excipient ingredients: synthetic beeswax; octyldodecanol; microcrystalline wax; cetyl palmitate; octyl palmitate; dibutyl adipate; pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate; bis-stearyl ethylenediamine/neopentyl glycol/stearyl hydrogenated dimer dilinoleate copolymer; colloidal anhydrous silica; tapioca starch; purified water; polymethylsilsesquioxane; dl-alpha-tocopheryl acetate - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

bondi sands pty ltd - homosalate, quantity: 100 mg/g; butyl methoxydibenzoylmethane, quantity: 30 mg/g; octyl salicylate, quantity: 50 mg/g; octocrylene, quantity: 100 mg/g; ethylhexyl triazone, quantity: 15 mg/g - spray - excipient ingredients: dl-alpha-tocopheryl acetate; ethanol absolute; cocoglycerides; dibutyl adipate; bis-stearyl ethylenediamine/neopentyl glycol/stearyl hydrogenated dimer dilinoleate copolymer; ppg-15 stearyl ether; pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate; isopropyl palmitate; octyl palmitate; fragrance (perfume) - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 30 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

bondi sands pty ltd - homosalate, quantity: 150 mg/g; butyl methoxydibenzoylmethane, quantity: 30 mg/g; octyl salicylate, quantity: 50 mg/g; octocrylene, quantity: 100 mg/g - spray - excipient ingredients: pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate; dl-alpha-tocopheryl acetate; dibutyl adipate; octyl palmitate; cocoglycerides; bis-stearyl ethylenediamine/neopentyl glycol/stearyl hydrogenated dimer dilinoleate copolymer; ethanol absolute; isopropyl palmitate; ppg-15 stearyl ether; fragrance (perfume) - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 30 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

bondi sands pty ltd - octyl salicylate, quantity: 50 mg/g; octocrylene, quantity: 100 mg/g; butyl methoxydibenzoylmethane, quantity: 30 mg/g; homosalate, quantity: 80 mg/g - spray - excipient ingredients: ethanol absolute; isopropyl palmitate; dl-alpha-tocopheryl acetate; ppg-15 stearyl ether; octyl palmitate; cocoglycerides; bis-stearyl ethylenediamine/neopentyl glycol/stearyl hydrogenated dimer dilinoleate copolymer; pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate; dibutyl adipate; fragrance (perfume) - spf 15 broad spectrum medium/moderate protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen)